Emcure's Marcan Pharma to Acquire Remaining Stake in Mantra Pharma
Emcure Pharmaceuticals' subsidiary Marcan Pharmaceuticals has signed agreements to acquire the remaining Class E Special Shares of Canada's Mantra Pharma, making the company a wholly owned subsidiary.
Mantra Pharma | 06/07/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy